Publications by authors named "Matthew D Hoplin"

Claim this Profile
A
A field resource for the glioma cerebrospinal fluid proteome: Impacts of resection and location on biomarker discovery.
Cecile Riviere-Cazaux, Christopher J Graser, Arthur E Warrington, Matthew D Hoplin, Katherine M Andersen

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Glioma Monitoring via Cerebrospinal Fluid Cell-Free DNA.
Cecile Riviere-Cazaux, Xiaoxi Dong, Wei Mo, Rahul Kumar, Chao Dai, Matthew D Hoplin

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dynamic impact of location and resection on the glioma CSF proteome.
Cecile Riviere-Cazaux, Christopher J Graser, Arthur E Warrington, Matthew D Hoplin, Katherine M Andersen

medRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma Metabolic Feedback In Situ: A First-In-Human Pharmacodynamic Trial of Difluoromethylornithine + AMXT-1501 Through High-Molecular Weight Microdialysis.
Cecile Riviere-Cazaux, Bryan J Neth, Matthew D Hoplin, Bambi Wessel, Jason Miska

Neurosurgery· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, William J Laxen, Amanda Munoz-Casabella, Matthew D Hoplin

Neurooncol Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas.
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, William J Laxen, Amanda Munoz-Casabella, Matthew D Hoplin

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis